poster
Frontage Laboratories has developed and validated a highly sensitive, GxP-qualified dPCR-based RCL (replication-competent lentivirus) assay to monitor the safety of clinical samples. Targeting the VSV-G gene, this assay offers absolute quantification with a LoD as low as 0.05 copies/µL. It delivers exceptional accuracy, precision, and cross-platform performance. With industry-leading sensitivity and compliance with FDA guidance, Frontage’s RCL assay ensures robust detection of rare recombination events and supports regulatory submission with exceptional analytical confidence.
Register to gain access to gated resources.
"*" indicates required fields
Frontage Laboratories websites use cookies. By continuing to browse the site you are agreeing to our use of cookies. For more details about cookies, and their use, please see our privacy policy.
Websites store cookies to enhance functionality and personalise your experience. You can manage your preferences, but blocking some cookies may impact site performance and services.
Essential cookies enable basic functions and are necessary for the proper function of the website.